Prognostic impact of somatic mutations and additional chromosomal abnormalities in patients with myelodysplastic syndromes and chromosome 20q deletion
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Myelodysplastic syndrome with 20q deletion (del(20q)) and additional chromosomal abnormalities (ACAs) shows more molecular mutations and poorer survival. Isolated del(20q) has a better prognosis than del(20q) with ACAs.
Area Of Science
- Hematology
- Cytogenetics
- Molecular Biology
Background
- The 20q deletion (del(20q)) is a common chromosomal abnormality in myelodysplastic syndrome (MDS).
- Isolated del(20q) is generally associated with favorable outcomes in MDS.
- The prognostic impact of del(20q) in conjunction with other chromosomal abnormalities requires further investigation.
Purpose Of The Study
- To analyze the clinical features and prognostic significance of del(20q) in MDS.
- To evaluate the impact of additional chromosome abnormalities (ACAs) on outcomes in patients with del(20q).
- To investigate the association between cytogenetic and molecular alterations and survival in del(20q) MDS.
Main Methods
- Retrospective analysis of 1,527 MDS patients, identifying 101 with del(20q).
- Classification of del(20q) cases into isolated del(20q), del(20q) with one ACA, and del(20q) with ≥2 ACAs.
- Cytogenetic and molecular mutation profiling, including analysis of TET2 and U2AF1 mutations.
Main Results
- Patients with del(20q) and ≥2 ACAs had significantly shorter overall survival (OS) and leukemia-free survival (LFS) compared to those with isolated del(20q) or one ACA.
- The del(20q) with ACAs subgroup exhibited a higher incidence and number of molecular mutations.
- Multiple mutations within the same gene, particularly TET2, were observed, and patients with ≥2 mutations showed poorer OS and LFS.
- Multiple mutations, U2AF1, TET2 mutations, and ≥10% bone marrow blasts were independent predictors of poorer OS.
Conclusions
- Del(20q) associated with ACAs in MDS indicates more molecular abnormalities and a worse prognosis compared to isolated del(20q).
- The presence of multiple molecular mutations, especially in TET2 and U2AF1, predicts poor survival in del(20q) MDS.
- These findings highlight the importance of comprehensive cytogenetic and molecular analysis for risk stratification in del(20q) MDS.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Overview
Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.
A Simple Chromosome Staining Technique Provides Valuable Scientific Insight
Some genetic diseases can be detected by...